By Mark Lundegren
Cancer has been in the news these last few weeks, and the news has been decidedly more hopeful than in the past.
Based on a series of recent studies and meta-analyses, scientists are now increasingly and more definitively prioritizing our risk factors for many common and aggressive cancers, allowing us all to reduce our chances of getting these diseases by as much as half. And at least as importantly, long-envisioned immunotherapy regimes for treating existing cancers are entering clinical trials and showing early results that are promising if not remarkable.
Let’s begin a recap of recent cancer news by highlighting a new and quite extensive study of factors leading to common cancers that was recently published in the British Journal of Cancer (BJC). It concluded that readily alterable lifestyle choices accounted for over 40% of cancers in the UK, prompting calls there for urgent public action. These high-risk factors include: 1) smoking, 2) being overweight, 3) an unnatural absence of fruits and vegetables from our diet, 4) excessive alcohol consumption, and 5) immoderate sun and UV exposure. These new findings build on prior research showing that inadequate exercise also can be an important direct and indirect (especially by influencing body weight) lifestyle risk factor for cancer.
There’s more. The BJC published another new cancer study, this one based on research conducted by the Karolinska Institute in Sweden. Its findings were consistent with widespread and still growing research linking red meat and processed meats to increased cancers. The new study specifically suggested an almost 20% increased risk of deadly pancreatic cancer for each 50 grams (2 ounces) of processed meat consumed each day.
In addition to this more definitive cancer prevention guidance, Sharon Begley’s recent article, Could This Be The End of Cancer, is especially notable and newsworthy. In it, Begley summarizes promising, even startling early results from current clinical trials of new cancer vaccine therapies. Unlike traditional vaccines that prevent viral infections, the new cancer vaccines are instead used to trigger the body to attack cancers that have already formed.
The emerging cancer vaccines do this in a way similar to vaccines generally, by introducing an antigen that elicits an immune system response. But in this case, instead of a marker or weakened version of a target virus, the antigen is a surface molecule unique to the developing cancer, which in theory can cause the body to produce antibodies that will steadily defeat the cancer. You can review Begley’s excellent synopsis to learn more about the technique and the impressive initial clinical results.
So, do you want to take proven steps to greatly reduce your cancer risk, while we all wait to see if vaccine-based cancer therapies will be a medical breakthrough and work as well as some hope? You can address the majority of your most important lifestyle-related cancer risks through two simple and science-based HumanaNatura health techniques, Natural Eating and Natural Exercise. And you also can tackle deeper health risks and pursue waiting quality of life opportunities through HumanaNatura’s other two techniques, Natural Living and Natural Communities.
All four techniques are part of HumanaNatura’s comprehensive natural health system and are explained in detail in our complete and naturally open-ended Personal Health Program. If you want to start by learning more about HumanaNatura and your key opportunities for transformed modern natural health, go to The Four HumanaNatura Techniques.
Photo courtesy of Vegetables.
Mark Lundegren is the founder of HumanaNatura.
Tell your friends about HumanaNatura…promote new life and health!